Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

van der Gouwe D

40 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Safety 19 Review Article 18 Depression 17 Addiction 10 Receptor Pharmacology 9 Pharmacology 8 Clinical Trial 8 Systematic Review 8 Randomized Controlled Trial 6 Mechanism of Action 5 Toxicity 5 Treatment-Resistant Depression 5

Journals

Journal of psychopharmacology (Oxford, England) 3 CNS drugs 2 Clinical Pharmacokinetics 2 JAMA psychiatry 2 Psychopharmacology 2 Tijdschrift voor psychiatrie 2 Clinical toxicology (Philadelphia, Pa.) 1 The Journal of Clinical Psychiatry 1

Publication history

Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.Clinical toxicology (Philadelphia, Pa.) · 2026-06-23 Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-13 Psilocybin use among Basotho healers and non-healers in southern AfricaOSF Preprints · 2026-04-23 Discovery of the closest free-living relative of the domesticated 'magic mushroom' Psilocybe cubensis in Africa.Proceedings. Biological sciences · 2026-03-11 Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.CNS drugs · 2026-03-01 Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.Psychedelic medicine (New Rochelle, N.Y.) · 2026-03-01 COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSISThe Study of Phenomena Related to Health · 2026-01-01 Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics.Current topics in behavioral neurosciences · 2026-01-01 A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.Journal of psychopharmacology (Oxford, England) · 2026-01-01 Concomitant use of antidepressants and classic psychedelics: A scoping review.Journal of psychopharmacology (Oxford, England) · 2025-10-01 Psilocybin for disorders of consciousness: A case-report study.Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology · 2025-05-01 Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A surveyJournal of Psychedelic Studies · 2025-04-22 630. Synthetic Psilocybin (COMP360) for Chronic Active Suicidal Ideation: An Open-Label StudyBiological Psychiatry · 2025-04-09 Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc AnalysisClinical Pharmacokinetics · 2025-03-01 Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.Progress in neuro-psychopharmacology & biological psychiatry · 2025-01-10 Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial.The American journal of psychiatry · 2025-01-01 Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc AnalysisClinical Pharmacokinetics · 2025-01-01 Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine.Journal of psychoactive drugs · 2025-01-01 Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need.Current psychiatry reports · 2024-12-01 Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.CNS drugs · 2024-10-01 Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.JAMA psychiatry · 2024-06-01 Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.JAMA psychiatry · 2024-06-01 Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.Scientific reports · 2024-02-05 [Feeling unwell after eating a piece of chocolate].Nederlands tijdschrift voor geneeskunde · 2023-11-23 LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain.South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde · 2023-11-06 Are psychedelics the answer to chronic pain: A review of current literature.Pain practice: the official journal of World Institute of Pain · 2023-04-01 Therapeutic effect of psilocybin in addiction: A systematic review.Frontiers in psychiatry · 2023-01-01 Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.Journal of psychopharmacology (Oxford, England) · 2022-10-01 The therapeutic potential of psilocybin: a systematic review.Expert opinion on drug safety · 2022-06-01 How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.Psychopharmacology · 2022-06-01 Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.Psychopharmacology · 2022-01-01 Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without.European journal of neurology · 2021-07-31 Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug AnalysisCurrent Addiction Reports · 2021-07-26 [Psychedelics in the treatment of PTSD].Tijdschrift voor psychiatrie · 2020-01-01 [Psychedelics for existential distress in terminally ill patients].Tijdschrift voor psychiatrie · 2020-01-01 Second and third year medical students' self-reported alcohol and substance use, smoking habits and academic performance at a South African medical school.Health SA = SA Gesondheid · 2018-12-31 Anticholinergic toxicity after the ingestion of serotonergic 'magic mushrooms'Netherlands Journal of Critical Care · 2012-06-01 Harm potential of magic mushroom use: a review.Regulatory toxicology and pharmacology: RTP · 2011-03-31 Khat and mushrooms associated with psychosis.The world journal of biological psychiatry: the official journal of the World Federation of Societies of Biological Psychiatry · 2004-01-01 Patterns of recreational drug use at dance events in Edinburgh, Scotland.Addiction (Abingdon, England) · 2001-07-01

Author directory